Skip to main content
. 2024 Apr 10;13(8):2193. doi: 10.3390/jcm13082193

Table 4.

Summary of ESUR vs. ACR guidelines concerning GBCAs administration in pregnant and lactating women.

ESUR ACR
Pregnant women with preserved renal function Smallest quantity of macrocyclic GBCAs only; very strong clinical indication to contrast enhanced MRI Smallest quantity of macrocyclic GBCAs only; very strong clinical indication to contrast enhanced MRI
Pregnant women with impaired renal function GBCAs formally contraindicated Same safety measures as in non-pregnant women
Lactating women with preserved renal function No breast-feeding interruption formally required No breast-feeding interruption formally required
Lactating women with impaired renal function GBCAs formally contraindicated Same safety measures as in non-pregnant women